期刊文献+

缺血性脑卒中二级预防探讨 被引量:3

下载PDF
导出
摘要 在我国存活的脑卒中患者达600万-700万。缺血性脑卒中占所有类型脑卒中的85%左右,〈45岁的脑卒中发病率为9.77%。复发性脑卒中较首次发生的脑卒中更易导致严重的致残,而且预后也更差。脑卒中二级预防的主要目的是为了预防或降低再次发生脑卒中的危险和降低致残率,干预危险因素是脑卒中二级预防的重要手段,包括控制血压、治疗糖尿病、降低胆固醇、抗血小板治疗、控制体重、戒烟、戒酒、体力活动等措施。
出处 《中国疗养医学》 2009年第10期892-892,共1页 Chinese Journal of Convalescent Medicine
  • 相关文献

参考文献4

二级参考文献16

  • 1明淑萍,张晓琴.感染与缺血性脑卒中[J].卒中与神经疾病,2004,11(4):246-248. 被引量:6
  • 2Antithrombotic Trialists′ Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324:71-86.
  • 3Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events.The SALT Collaborative Group.Lancet,1991,338:1345-1349.
  • 4European Stroke Prevention Study 2.Efficacy and safety data.J Neurol Sci,1997,151 Suppl:S1-S77.
  • 5Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke.EAFT (European Atrial Fibrillation Trial) Study Group.Lancet,1993,342:1255-1262.
  • 6Ridker PM,Cook NR,Lee IM,et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.N Engl J Med,2005,352:1293-1304.
  • 7The International Stroke Trial (IST):a randomised trial of aspirin,subcutaneous heparin,both,or neither among 19435 patients with acute ischaemic stroke.International Stroke Trial Collaborative Group.Lancet,1997,349:1569-1581.
  • 8CAST:randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke.CAST (Chinese Acute Stroke Trial) Collaborative Group.Lancet,1997,349:1641-1649.
  • 9ISIS-2 Collaborative Group.Randomized trial of intravenous streptokinase,oral aspirin,both,or neither among 17187 cases of suspected acute myocardial infarction:ISIS-2.Lancet,1988,Ⅱ:349.
  • 10Antithrombotic Trialists' Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324(7329):71-86,324(7330):141.

共引文献90

同被引文献20

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部